EASL Journal Club: Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD

Join us for an engaging discussion on a significant recent study: “Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.” This European multicentre study investigates the prognostic role of HVPG in metabolic dysfunction-associated steatotic liver disease (MASLD)-related compensated advanced chronic liver disease (cACLD), focusing on portal hypertension as a driver of hepatic decompensation.